Sanofi Unit To Pay $180M In Disease Treatment Patent Fight
A U.S. subsidiary of the French multinational pharmaceutical corporation Sanofi SA has agreed to pay $180 million to resolve a dispute with a Taiwanese company over patents aimed at treating a...To view the full article, register now.
Already a subscriber? Click here to view full article